Ligand-induced activation of the epidermal growth factor receptor (EGFR) initiates multiple signal-transduction pathways as well as trafficking events that relocalize the receptors from the cell surface to intracellular endocytic compartments. Although there is growing awareness that endocytic transport can play a direct role in signal specification, relatively little is known about the molecular mechanisms underlying this link. Here we show that human Sprouty 2 (hSpry2), a protein that has been implicated in the negative regulation of receptor tyrosine kinase (RTK) signaling [1], interferes with the trafficking of activated EGFR specifically at the step of progression from early to late endosomes. This effect is mediated by the binding of hSpry2 to the endocytic regulatory protein, hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), and leads to a block in intracellular signal propagation. These observations suggest that EGFR signaling is controlled by a novel mechanism involving trafficking-dependent alterations in receptor compartmentalization.
Summary
Ligand-induced activation of the epidermal growth factor receptor (EGFR) initiates multiple signal-transduction pathways as well as trafficking events that relocalize the receptors from the cell surface to intracellular endocytic compartments. Although there is growing awareness that endocytic transport can play a direct role in signal specification, relatively little is known about the molecular mechanisms underlying this link. Here we show that human Sprouty 2 (hSpry2), a protein that has been implicated in the negative regulation of receptor tyrosine kinase (RTK) signaling [1] , interferes with the trafficking of activated EGFR specifically at the step of progression from early to late endosomes. This effect is mediated by the binding of hSpry2 to the endocytic regulatory protein, hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), and leads to a block in intracellular signal propagation. These observations suggest that EGFR signaling is controlled by a novel mechanism involving trafficking-dependent alterations in receptor compartmentalization.
Results and Discussion
The signal output of RTKs is under the tight control of positive and negative regulators. Sprouty (Spry) proteins comprise a family of structurally related negativefeedback regulators of RTK signaling. Because of their ability to interact with various signaling molecules, Spry proteins are thought to exert their inhibitory effects by interfering with the formation of signaling complexes that are required for RTK-mediated signal flow [2] . However, the spatio-temporal regulation of these interactions remains largely unknown. Several studies have reported the presence of Spry proteins in cytoplasmic vesicular structures [3] [4] [5] [6] . Moreover, in some cases these structures have been shown to contain internalized EGFRs, indicating their endosomal nature [3, 5] . Given the well-established link between the endocytic fate of RTKs and their signaling capacity, we sought to determine the functional significance of endosomelocalized Spry.
Because most Spry localization studies carried out to date have been performed with ectopically expressed Spry, we set out to examine the localization of endogenous Spry2 by indirect immunofluorescence staining by using Spry2 antibody. To this end, we have exploited two cell lines, C2C12 murine myoblasts and MIAPaCa-2 human pancreatic tumor cells, in which the expression levels of Spry were found to be relatively high ( [7] , our unpublished observation). As illustrated in Figure 1A and Figure S1A , the staining pattern of endogenous Spry2 consisted predominantly of cytoplasmic Spry2-enriched punctae. We ascertained the specificity of staining from the fact that the preabsorption of the antibodies with purified Spry2 proteins abrogated the immunofluorescence signal ( Figure S1A ).
In order to determine the identity of the Spry2-containing structures, we examined the colocalization of Spry2 with the early-endosomal marker Rab5 or the late-endosomal marker Rab7. Under serum-deprived conditions, there was no detectable colocalization between Spry2 and Rab5 ( Figure 1A ). However, after EGF stimulation, most of the Spry2-containing structures were found juxtaposed to Rab5-positive endosomes ( Figure 1A ). The spatial overlap between Spry2 and early endosomes was detected as early as 10 min after EGF addition and persisted for up to 2 hr. The same localization pattern was displayed by ectopically expressed hSpry2 ( Figure S1B ). Moreover, no colocalization of hSpry2 and Rab7 was observed at any point after EGF addition ( Figure S1C ). Together, these observations indicate that ligand-dependent activation of EGFR induces the stable association of Spry2 with early endosomes. Based on colocalization studies with caveolin, it appears that most of the Spry2-containing structures observed in the absence of growth-factor stimulation correspond to the caveosome ( Figure S1D ).
Endocytosis is widely viewed as a means to terminating signaling via degradation of activated receptor complexes after their internalization from the cell surface. However, recent studies have uncovered a role for endocytic organelles as signaling platforms [8] . Given the EGF-dependent association of hSpry2 with the early endosome, we have reasoned that it might function by affecting the endocytic trafficking of EGFR. To test this idea, we monitored the endocytic movement of EGFR in the presence or absence of hSpry2. Within 10 min of EGF stimulation, most of the ligand-bound receptors were found in early endosomes, as evidenced by their colocalization with the early endosomal marker EEA1 ( Figures 1B and 1C) . By 30 min, approximately 60%-70% of the receptor molecules colocalized with Rab7, indicating their progression to late-endosomal compartments ( Figures 1D and 1E ). In contrast, in cells expressing hSpry2, only 30% of the receptors translocated to late-endosomal compartments, whereas 70% remained associated with early endosomes up to 2 hr after stimulation ( Figures 1C and 1E ). The same effect was observed with an hSpry2 mutant that cannot interact with c-Cbl (DCbl) (Figures 1C and 1E ). These observations indicate that hSpry2 expression interferes with the trafficking of EGFR from early to late endosomes through a c-Cbl independent mechanism. As might be predicted, this trafficking defect is associated with the attenuation of ligand-induced EGFR degradation ( Figures S2A and S2B) .
To rule out the possibility that the effects of hSpry2 on EGFR trafficking are due to overexpression, we have examined the endocytic fate of EGFR in cells depleted of hSpry2 by RNA interference (RNAi). For this analysis, we elected to use the pancreatic cancer cell line MIAPaCa-2 because the endogenous levels of Spry2 are constitutively high in these cells. As illustrated in Figure 2A , the expression of hSpry2 shRNA was accompanied by a substantial reduction (approximately 90%) in the level of hSpry2 protein. In cells expressing control shRNA, stimulation with Texas red EGF rapidly induced receptor internalization and trafficking to early endosomes, as evidenced by their colocalization with EEA1 ( Figure 2B , 10 min). However, endocytic progression beyond this step was halted; the ligand-bound EGFR remained associated with EEA1-positive structures for up to 2 hr ( Figures 2B and 2C ). In contrast, in hSpry2-depleted cells, EGFRs gradually dissociated from early endosomes, as illustrated by decreased colocalization with EEA1 over time ( Figures 2B and 2C ) and the accumulation of the receptor in the LAMP1-positive lateendosomal compartment ( Figure S3 ). The effect of hSpry2 shRNA was reversed in the presence of the shRNA-insensitive hSpry2 mutant, indicating that the consequences of hSpry2 shRNA expression reflect the specific targeting of hSpry2 ( Figures 2D and 2E ). These observations are in agreement with the hSpry2 ectopic expression data ( Figure 1 ) and provide further support for the idea that hSpry2 interferes with the progression of internalized receptors from early to late endosomes.
We have observed that the majority of EGFR-containing endosomes in hSpry2-expressing cells are also positive for hSpry2 ( Figure S4 ). This observation suggests that hSpry2 might exert its effect on EGFR trafficking by targeting the endocytic sorting machinery itself. The sorting of activated EGFR from early to late endosomes has been shown to depend on the multidomain protein Hrs [9] . Consequently, Hrs loss of function or overexpression results in the accumulation of EGFR in enlarged early endosomes [10, 11] . Given the resemblance of this effect to that induced by the expression of hSpry2, we have examined the possibility that hSpry2 inhibits EGFR trafficking by modulating Hrs function at early endosomes. As illustrated in Figures 3A-3C , hSpry2 interacts with Hrs in a time-dependent manner after the addition of EGF, and this interaction takes place at the early endosome ( Figure S5A ).
The role of Hrs in promoting endocytic sorting is accomplished through multiple protein-protein interactions. Of particular relevance to this study is the recent demonstration that Hrs binds directly to the tumorsusceptibility gene 101 (Tsg101) and that this binding is required for EGFR transport from early to late endosomes [12] [13] [14] . As illustrated in Figure 3D , the expression of hSpry2 resulted in a dose-dependent attenuation of Hrs/Tsg101 interactions. Conversely, increasing the amount of Tsg101 disrupted the hSpry2 and Hrs interaction, indicating that hSpry2 competes with Tsg101 for binding to Hrs ( Figure S5B ). The expression of hSpry2 had no effect on Hrs tyrosine phosphorylation ( Figure S5C ) or endosomal localization ( Figure S5D ). Taken together, these results support the idea that hSpry2 may impede EGFR exit from early endosomes by interfering with the interaction of Hrs with Tsg101.
In order to confirm that the interaction of hSpry2 with Hrs is required for its interference with EGFR trafficking, we have utilized a serine-phosphorylation-deficient hSpry2 mutant, hSpry2 S112A/S121A [15] , which in comparison to wild-type hSpry2 displays a markedly reduced ability to interact with Hrs ( Figure 3E ) and compete off Tsg101 ( Figure 3F) . Significantly, the movement of EGFR from early to late endosomes was not altered in the presence of hSpry2 S112A/S121A (Figures 3G and  3H) . Likewise, the hSpry2-induced attenuation of liganddependent EGFR degradation did not take place upon the expression of hSpry2 S112A/S121A ( Figures S2A  and S2B ). Together, these results indicate that the inhibitory effect of hSpry2 on the trafficking of EGFR from early to late endosomes is dependent on hSpry2/Hrs interaction. The molecular details of these interactions and the extent to which they represent a direct association between the two proteins remain to be established.
It is becoming increasingly recognized that the ordered propagation of mitogen-activated protein kinase (MAPK) activation from the plasma membrane to earlyand late-endosomal compartments directly contributes to both signal output and biological outcome [8, 16, 17] . Because hSpry2 hinders the movement of activated receptors through the endocytic pathway, this effect could influence the spatial segregation of signaling events along the endocytic pathway. To examine this possibility, we assessed the spatiotemporal activation of the RTK-Ras-ERK cascade by fluorescence microscopy. Early and late endosomes can be often distinguished on the basis of their morphological appearance; whereas early endosomes are located primarily in the cell periphery, late endosomes are oriented closer to the nucleus and often form enlarged structures [18, 19] . To ascertain the applicability of this morphological distinction to the experimental system used in the present study, we stained the endocytic structures with the relevant markers and assessed their proximity to the nucleus by nuclear counterstaining with 4 0 6-diamidino-2-phenylindole (DAPI) (data not shown). Employing these criteria, we used Texas red EGF and an antibody that recognizes only the phosphorylated form of ERK to determine the subcellular localization of endocytosed receptors and activated ERK in each of these compartments. In unstimulated cells, most ligand-bound EGFRs were detected at the plasma membrane, and there was no significant pERK staining ( Figure 4A, upper panel) . However, after 10 min of EGF stimulation, an increase of pERK staining was observed in peripheral early endosomes, where pERK colocalized with Texas red EGF ( Figure 4A, middle panel) . After 30 min of stimulation, Texas red EGF and pERK signals relocalized to the enlarged perinuclear compartments corresponding to late endosomes ( Figure 4A, lower panel) . A similar movement of pERK signal along the endocytic pathway upon EGF stimulation has also been demonstrated in an earlier study [20] . This relocalization event was blocked (E) Quantification of EGFR trafficking to early endosomes in MIAPaCa-2 cells. Cells were transfected with control and hSpry2 shRNA with/ without hSpry2 mut and serum starved for 16 hr. Cells were stimulated with 100 ng/ml Texas red EGF (TR-EGF) for 60 min and stained with EEA1 antibody. Data are presented as described in (C). Error bars represent the standard error of the mean (SEM); differences between experiments were examined with the Student's t test (*p < 0.05). (E) hSpry2 S112A/S121A mutant does not interact with Hrs. CHOK1 cells were transfected with Flag-Hrs together with either HA-hSpry2 or HA-hSpry2 S112A/S121A expression plasmid. IP and IB were carried out with the indicated antibodies. (F) CHOK1 cells were transfected with Flag-Hrs, Myc-Tsg101, and hSpry2 constructs as indicated. IP and IB were carried out with the indicated antibodies.
(G) COS-1 cells were serum starved and transfected with GFP-Rab7 and the indicated hSpry2 constructs. Cells were stimulated with 100 ng/ml Texas red EGF (TR-EGF) for 60 min and immunostained with Spry2 antibody (blue). Scale bars represent 10 mm. (H) Quantification of EGFR trafficking to late endosomes. Data are presented as described in Figure 1E . Error bars represent SEM; differences between experiments were examined with the Student's t test (*p < 0.05).
in cells expressing hSpry2 ( Figures 4B and 4C) . Instead, in these cells, pERK and activated EGFR remained associated with the peripheral early endosomal compartments ( Figure 4B, lower panel) . These observations indicate that hSpry2 interferes with the ordered progression of ERK signal from early to late endosomes. A similar regulatory principle governs the activity of another negative regulator of RTK signaling, Sef (protein product of sef, similar expression to fgf genes), which resides in the Golgi apparatus and inhibits MEK/ERK signaling specifically in this location [21] . Thus,the spatial restriction of ERK activity may constitute a common mode by which regulators of RTK signaling operate.
Multiple lines of evidence indicate that the sorting of receptors to different membrane-bound compartments plays a critical role in specifying a signaling outcome [22, 23] . Consequently, the regulation of receptor delivery to subsequent endocytic compartments is under tight spatial and temporal control. Our findings that the endocytic maturation of the EGFR is intercepted by hSpry2 indicate that the antagonistic effects of hSpry2 may be exerted through perturbations in the localization of EGFR signaling. As a consequence of the induced defect in the exit of activated EGFR from the early endosome, hSpry2 expression prevents the accumulation of active ERK in late endosomes. The significance of signal propagation through the late endosomes is supported by the recent finding that the localization of the MP-1/ MAPK scaffold to late endosomes via p14 is required for full EGF-induced ERK activation and underscores the significance of signal propagation through the late endosomes [20] .
In biochemical studies, Spry has been shown to potentiate EGFR-induced ERK activation [24, 25] . A priori, these observations are not consistent with the genetically ascribed function of Spry as a negative regulator of EGFR signaling. Our findings provide a possible resolution for this apparent discrepancy by demonstrating that the localization of EGF-induced ERK activation rather than the absolute level of activation is the critical signaling event targeted by hSpry2. In addition to EGFR, Spry has been shown to antagonize signaling downstream of several other RTKs [1] . Because different signaling systems may depend on endosomes to varying degrees, it remains to be clarified to what extent perturbations in receptor trafficking constitute a more general mechanism by which Spry exerts its effect on RTK signaling.
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